Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States
Clinical trial NCT05870839 · COMPLETED
Trial details
- NCT number
- NCT05870839
- Sponsor
- Vaccine Company, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2024-04-10
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.